Four New Biotechs LaunchAutoimmune Diseases, Digital Health, Financing, Investors, Limb-Girdle Muscular Dystrophy (LGMD), Metabolomics, Non-alcoholic steatohepatitis (NASH), Parkinson's Disease, Series A, Venture CapitalFour biotech companies announced Series A rounds: Vita Therapeutics, NuvoAir, Enveda Biosciences, and ImmuneID. Read more June 23, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/06/Four-New-Biotechs-Launch-to-Combat-MD-NASH-Parkinsons-and-More-BioSpace-6-23-21.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-06-23 19:09:032021-06-23 19:12:32Four New Biotechs Launch